China

Wound care is set to maintain slow and stable retail current value growth in China in 2024. The category remains highly concentrated, with Yunnan Baiyao and Band-Aid holding significant value shares. These two brands are expected to lead value sales…

As consumers are pursuing diverse ways to achieve a healthy physique, weight management and wellbeing is expected to continue its downward trend in China in retail current value terms in 2024, with a low single-digit decrease, extending the decline…

After the surge in demand for vitamins in China in 2022, related to the reopening of the country after COVID-19 restrictions, vitamins experienced a slight retail current value decline in 2023, primarily driven by corrections for multivitamins and…

As the pandemic has ended, Chinese consumers are gradually resuming their fitness habits, and sales of sports nutrition are expected to continue to grow in 2024, with high single-digit retail current value growth expected. Specifically, while sports…

Although it remains a relatively small category within consumer health in China, sleep aids has experienced several years of robust growth, and is projected to continue to achieve double-digit expansion in retail current value terms in 2024. With the…

Paediatric consumer health is set to maintain solid although slower retail current value growth in China in 2024, and it is projected to maintain a high single-digit CAGR moving forward, with continued upgrades in consumer preferences when it comes…

In 2024, herbal/traditional products is set to maintain retail current value growth in China, although this will be at a lower level than for several years. Although higher than the average for herbal/traditional products, herbal/traditional dietary…

Eye care is set to maintain moderate retail current value growth in China in 2024, driven by the only category with notable sales, standard eye care. Dry eye disease is becoming increasingly prevalent amongst younger populations in China,…

Digestive remedies has experienced significant demand fluctuations in China following the easing of COVID-19 restrictions. While certain categories saw explosive growth due to pandemic-related digestive issues in 2023, this surge is expected to…

Following high growth in 2023, the first year after the lifting of pandemic restrictions, the retail current value growth rate for dietary supplements in China is expected to slow down in 2024, below the review period CAGR, as a counterbalance to the…

Dermatologicals is expected to register mild but steady retail current value growth in China in 2024, propelled by the prevalence of dermatological problems amongst a vast population. Skin infections, dermatitis, and eczema are particularly common,…

Sales of cough and cold remedies have gradually been normalising in China in 2024, although from a high base established in 2023 during the wave of COVID-19 infections. Persistent respiratory illnesses throughout late 2023 and early 2024 have…

Consumer health in China is expected to record low single-digit retail current value growth in 2024, with the surge in demand for consumer health products during the COVID-19 pandemic subsiding, and growth rates returning to the pre-pandemic level.…

Systemic analgesics, represented mainly by ibuprofen, witnessed an extraordinary surge in demand in China during the first and second quarters of 2023. This unprecedented growth was a direct consequence of the lifting of lockdown restrictions in the…

Connected and autonomous vehicles are becoming more widespread, reflecting the automotive industry's digital and technological shift. This report sizes the autonomous vehicle market, specifying the countries and brands embracing driverless…

2024 is expected to be a year of continued strong recovery in the number of domestic as well as cross-border trips in China. Although domestic long-haul travel remains relatively down, this is expected to be more than offset by the strong recovery of…

2024 is expected to be a year of continued strong rebound for domestic tourism. According to Euromonitor International, domestic trips are set to grow by 24% in 2024, returning to 92% of the pre-pandemic level. Meanwhile, domestic spending is…

Hotels is set to see another strong year in China in 2024, continuing its rebound in retail current value terms, although will be unable to return to the pre-pandemic (2019) level of sales. Nevertheless, the category continues to benefit from the…

According to the Ministry of Culture and Tourism, travel intermediaries in China organised 132 million domestic trips in 2023, although this accounted for less than 3% of total domestic trips in the same year. Consumers increasingly favour…

Airlines in China is set to maintain growth momentum in retail current value terms in 2024, along with the release of pent-up demand after the pandemic, and the return of cross-border travel. Passenger volumes were recorded at 351 million in the…